[Federal Register Volume 81, Number 93 (Friday, May 13, 2016)]
[Notices]
[Pages 29853-29854]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11342]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Defense Health Board; Notice of Federal Advisory Committee 
Meeting

AGENCY: Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce that the following Federal Advisory Committee meeting of the 
Defense Health Board will take place.

DATES: 

Thursday, June 2, 2016

9:00 a.m.-10:15 a.m. (Closed Session)
10:15 a.m.-11:45 a.m. (Open Session)
11:45 a.m.-12:45 p.m. (Administrative Session)
12:45 p.m.-5:00 p.m. (Open Session)

ADDRESSES: Defense Health Headquarters (DHHQ), Pavilion Salons B-C, 
7700 Arlington Blvd., Falls Church, Virginia 22042 (escort required; 
see guidance in SUPPLEMENTARY INFORMATION, ``Public's Accessibility to 
the Meeting'').

FOR FURTHER INFORMATION CONTACT: The Executive Director of the Defense 
Health Board is Ms. Christine Bader, 7700 Arlington Boulevard, Suite 
5101, Falls Church, Virginia 22042, (703) 681-6653, Fax: (703) 681-
9539, [email protected]. For meeting information, please 
contact Ms. Kendal Brown, 7700 Arlington Boulevard, Suite 5101, Falls 
Church, Virginia 22042, [email protected], (703) 681-6670, 
Fax: (703) 681-9539.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., 
Appendix, as amended), the Government in the Sunshine Act of 1976 (5 
U.S.C. 552b, as amended), and 41 CFR 102-3.150.
    Additional information, including the agenda and electronic 
registration, is available at the DHB Web site, http://www.health.mil/About-MHS/Other-MHS-Organizations/Defense-Health-Board/Meetings.

Purpose of the Meeting

    The purpose of the meeting is to provide progress updates on 
specific taskings before the DHB. In addition, the DHB will receive 
information briefings on current issues or lessons learned related to 
military medicine, health policy, health research, disease/injury 
prevention, health promotion, and healthcare delivery.

Agenda

    Pursuant to 5 U.S.C. 552b and 41 CFR 102-3.155, in the interest of 
national security, the DoD has determined that the first presentation 
in the morning of June 2, 2016 will be closed to the public. The topic 
is a presentation on the mission and functions of the National Center 
for Medical Intelligence. The Assistant Secretary of Defense (Health 
Affairs), in consultation with the Office of the DoD General Counsel, 
has determined in writing that the public interest requires that the 
first presentation in the morning session on June 2, 2016 be closed to 
the public because it will concern matters listed in section 552b(c)(1) 
of title 5, United States Code. The classified materials are so 
inextricably intertwined with the unclassified material that they 
cannot be reasonably segregated into separate discussions without 
disclosing SECRET material. Specifically, the information presented 
meets criteria established by an Executive Order to be kept secret in 
the interest of national defense and foreign policy.
    Pursuant to 5 U.S.C. 552b and 41 CFR 102-3.140 through 102-3.165 
and subject to availability of space, the DHB meeting is open to the 
public from 10:15 a.m. to 11:45 a.m. on June 2, 2016, and from 12:45 
p.m. to 5:00 p.m. The DHB will receive a progress update from the 
Health Care Delivery Subcommittee on the pediatric clinical preventive 
services review and an update from the Public Health Subcommittee on 
their review of improving Defense Health Program medical research 
processes. In addition, the DHB anticipates receiving information 
briefings on Defense Advanced Research Projects Agency medical 
research, the Army Study to Assess Risk and Resilience in 
Servicemembers (STARRS), the Infectious Disease Clinical Research 
Program, and Advances in the Use of Whole Blood for Combat Trauma 
Resuscitation. Any changes to the agenda can be found at the link 
provided in this SUPPLEMENTARY INFORMATION section.

Public's Accessibility to the Meeting

    Pursuant to 5 U.S.C. 552b, and 41 CFR 102-3.140 through 102-3.165 
and subject to availability of space, this meeting is open to the 
public. Seating is limited and is on a first-come basis. All

[[Page 29854]]

members of the public who wish to attend the public meeting must 
contact Ms. Kendal Brown at the number listed in the section FOR 
FURTHER INFORMATION CONTACT no later than 12:00 p.m. on Wednesday, May 
25, 2016 to register. Additional details will be provided to all 
registrants.

Special Accommodations

    Individuals requiring special accommodations to access the public 
meeting should contact Ms. Kendal Brown at least five (5) business days 
prior to the meeting so that appropriate arrangements can be made.

Written Statements

    Any member of the public wishing to provide comments to the DHB may 
do so in accordance with section 10(a)(3) of the Federal Advisory 
Committee Act, 41 CFR 102-3.105(j) and 102-3.140, and the procedures 
described in this notice.
    Individuals desiring to provide comments to the DHB may do so by 
submitting a written statement to the DHB Designated Federal Officer 
(DFO) (see FOR FURTHER INFORMATION CONTACT). Written statements should 
not be longer than two type-written pages and address the following 
details: The issue, discussion, and a recommended course of action. 
Supporting documentation may also be included, as needed, to establish 
the appropriate historical context and to provide any necessary 
background information.
    If the written statement is not received at least five (5) business 
days prior to the meeting, the DFO may choose to postpone consideration 
of the statement until the next open meeting.
    The DFO will review all timely submissions with the DHB President 
and ensure they are provided to members of the DHB before the meeting 
that is subject to this notice. After reviewing the written comments, 
the President and the DFO may choose to invite the submitter to orally 
present their issue during an open portion of this meeting or at a 
future meeting. The DFO, in consultation with the DHB President, may 
allot time for members of the public to present their issues for review 
and discussion by the Defense Health Board.

    Dated: May 10, 2016.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2016-11342 Filed 5-12-16; 8:45 am]
BILLING CODE 5001-06-P